GB860704A - Injections of the antibiotic kamamycin - Google Patents

Injections of the antibiotic kamamycin

Info

Publication number
GB860704A
GB860704A GB10027/59A GB1002759A GB860704A GB 860704 A GB860704 A GB 860704A GB 10027/59 A GB10027/59 A GB 10027/59A GB 1002759 A GB1002759 A GB 1002759A GB 860704 A GB860704 A GB 860704A
Authority
GB
United Kingdom
Prior art keywords
acid
toxic
karamycin
kanamycin
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB10027/59A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Laboratories International SA
Original Assignee
Bristol Laboratories International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Laboratories International SA filed Critical Bristol Laboratories International SA
Publication of GB860704A publication Critical patent/GB860704A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Aqueous solutions of kanamycin are stabilized by the addition of a non-toxic salt of sulphurous acid, a non-toxic salt of hydrosulphurous acid, a non-toxic aldehyde addition product of sulphurous acid or of hydrosulphurous acid, monothioglycerol, monothiosorbitol, monothioglucose, beta, beta1-thiodipropionic acid, a non-toxic water-soluble ester of b ,b 1-thiodipropionic acid or a mixture thereof. The kanamycin may be a fermentation mixture of kanamycin A and B, kanamycin A, kanamycin B or a prepared mixture of kanamycin A and B. Specification 817,385 is referred to.ALSO:An aqueous injectable antibacterial composition comprises 100 to 700 mg. per ml. calculated as karamycin base, of a non-toxic water-soluble karamycin salt, 0.5 to 15 mg. per ml. of a stabilizing agent as hereinafter specified and from 2 to 50 mg. per ml. of buffering agent, the solution being adjusted to a pH of 4.0 to 8.2. A preferred composition contains 250 to 333 mg. per ml. of the karamycin (as base) and is adjusted to pH 4.0 to 6.5. The karamycin may be a fermentation mixture of karamycin A and B, karamycin A, karamycin B or a prepared mixture of karamycin A and B, especially a 1 : 1 mixture thereof. Specified stabilizing agents are a non-toxic salt of sulphurous acid, a non-toxic salt of hydro-sulphurous acid, a non-toxic aldehyde addition product of sulphurous acid, a non-toxic aldehyde addition product of hydrosulphurous acid, monothioglycerol, monothiosorbitol, monothioglucose, b ,b 1-thiodipropionic acid, a non-toxic water-soluble ester of b ,b 1-thiodipropionic acid or a mixture thereof. Preservatives such as phenol, chlorobutanol and methyl and/or butyl p-hydroxybenzoic acid may be present. The composition is prepared by adding the non-toxic karamycin salt to sterile water containing a buffering agent, adjusting the pH to 4.0 to 8.2, contacting the solution with activated charcoal, removing the charcoal and adding the stabilizing agent. Specification 817,385 is referred to.
GB10027/59A 1958-03-24 1959-03-23 Injections of the antibiotic kamamycin Expired GB860704A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US860704XA 1958-03-24 1958-03-24

Publications (1)

Publication Number Publication Date
GB860704A true GB860704A (en) 1961-02-08

Family

ID=22196051

Family Applications (1)

Application Number Title Priority Date Filing Date
GB10027/59A Expired GB860704A (en) 1958-03-24 1959-03-23 Injections of the antibiotic kamamycin

Country Status (1)

Country Link
GB (1) GB860704A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110483617A (en) * 2019-09-17 2019-11-22 陕西绿盾环境工程研究院有限公司 A kind of preparation method of high-content polyoxin original powder

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110483617A (en) * 2019-09-17 2019-11-22 陕西绿盾环境工程研究院有限公司 A kind of preparation method of high-content polyoxin original powder

Similar Documents

Publication Publication Date Title
GB992813A (en) Sterilization solution
GB860704A (en) Injections of the antibiotic kamamycin
US2566123A (en) Stable vitamin b12 solution
GB816592A (en) A method for the preparation of stable magnesium solutions of high concentration
Lowenthal et al. The Inhibition of Hyaluronidase by Sodium Salicylate and Its Possible Metabolites
GB1382008A (en) Fungicidal and/or bacterial composition and method
GB1049434A (en) Oxytetracycline
ES390952A1 (en) Procedure for the preparation of 2-piperidilcarbinols. (Machine-translation by Google Translate, not legally binding)
GB914893A (en) A new gibberellin and its derivatives and process for its production
GB855163A (en) Improvements in or relating to stabilized chymotrypsin solution
GB893418A (en) Process for the production of penicillin-splitting enzyme preparations
GB948623A (en) Poultry feed and supplements therefor
JPS5231020A (en) Process for preparation of lysine hydrate crystal
ES410091A1 (en) Production of citric acid from hydrocarbons
GB434984A (en) Process for preserving wood
ES243252A1 (en) Procedure for the production of a preparation of insulin of quick action (Machine-translation by Google Translate, not legally binding)
ES8206146A1 (en) A procedure for the preparation of a composition derived from chlorophenoxyacetic acid regulating vegetable growth. (Machine-translation by Google Translate, not legally binding)
GB1111871A (en) Cofactor u and a process for its production
GB916488A (en) New penicillin
GB922378A (en) Thiolo- and selenolo-phosphoric, -thionophosphoric, -phosphonic and -thionophosphonic acid esters
ES363661A1 (en) Procedure for the preparation of aminomethyl-2-pyrolidines-1-substitute. (Machine-translation by Google Translate, not legally binding)
GB902609A (en) Process for the preparation of gluconic acid monohydrate
GB856393A (en) A process for the manufacture of 4-amino-isoxazolidone-(3)
GB811770A (en) Method for hydrolyzing dextran
ES270671A2 (en) Procedure for obtaining fungicidal products (Machine-translation by Google Translate, not legally binding)